If a patient exhibits a hormone receptor-positive tumor, the majority of healthcare workers would initiate treatment with maintenance hormonal therapy following the completion of chemotherapy, despite the lack of prospective randomized trials regarding its efficacy (23). Here, NR4A1 is linked to neoplasm.